OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Inhibition of T-cell activity in alopecia areata: recent developments and new directions
Thierry Passeron, Brett King, Julien Séneschal, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 28

Showing 1-25 of 28 citing articles:

Properties of FDA-approved small molecule protein kinase inhibitors: A 2024 update
Robert Roskoski
Pharmacological Research (2024) Vol. 200, pp. 107059-107059
Open Access | Times Cited: 146

Pathogenesis of Alopecia Areata and Vitiligo: Commonalities and Differences
Hiroki L. Yamaguchi, Yuji Yamaguchi, Elena Peeva
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 8, pp. 4409-4409
Open Access | Times Cited: 12

Deciphering the Complex Immunopathogenesis of Alopecia Areata
Ingrid Šutić Udović, Nika Hlača, Larisa Prpić Massari, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 11, pp. 5652-5652
Open Access | Times Cited: 10

Baricitinib-Induced Remission of Alopecia Universalis in a Child with NFKB2-Associated Immune Dysregulation
Charlotte Blokhuis, Timothy Ronan Leahy, A.D. Irvine, et al.
Journal of Clinical Immunology (2025) Vol. 45, Iss. 1
Closed Access

Modern Management Approaches for Alopecia Areata
Eduard Т. Ambarchian, Vladislav V. Ivanchikov, Anastasia D. Kuzminova, et al.
Вопросы современной педиатрии (2025) Vol. 23, Iss. 6, pp. 516-522
Open Access

Dual improvement of alopecia areata and immune thrombocytopenia with baricitinib: a case report
Chelsea Moon, Sarah Park, Jennifer L. Hsiao, et al.
Skin Health and Disease (2025) Vol. 5, Iss. 1, pp. 66-69
Open Access

Efficacy, safety and tolerability of drugs for alopecia: a comprehensive review
Jair Alejandro Valdez-Zertuche, Hassiel Aurelio Ramírez-Marín, Antonellá Tosti
Expert Opinion on Drug Metabolism & Toxicology (2025)
Closed Access

Patterns of clinical response in patients with alopecia areata treated with ritlecitinib in the ALLEGRO clinical development programme
Brett King, Paradi Mirmirani, Kristen Lo Sicco, et al.
Journal of the European Academy of Dermatology and Venereology (2025)
Open Access

CS12192 Reverses Alopecia Areata by Selectively Targeting JAK3/JAK1/TBK1
Hui Jin, Zongyang Li, Xinwen Li, et al.
Advanced Biology (2025)
Open Access

Pathophysiology of Alopecia Areata in the Pediatric Patient
Madeline H. Fitzhugh, Jes B. Hansen, Ali Jabbari, et al.
Pediatric Dermatology (2025) Vol. 42, Iss. S1, pp. 24-30
Open Access

Genetic association between asthma and alopecia areata: A two‐sample Mendelian randomization study
W. Du, Ke He, Xin-Yi Liu, et al.
Skin Research and Technology (2024) Vol. 30, Iss. 7
Open Access | Times Cited: 2

A phase 2a study investigating the effects of ritlecitinib on brainstem auditory evoked potentials and intraepidermal nerve fiber histology in adults with alopecia areata
Samira Anderson, Guido Cavaletti, Linda J. Hood, et al.
Pharmacology Research & Perspectives (2024) Vol. 12, Iss. 4
Open Access | Times Cited: 2

Systematic review and indirect treatment comparisons of ritlecitinib against baricitinib in alopecia areata
David Aceituno, Chistopher Fawsitt, Gerard Power, et al.
Journal of the European Academy of Dermatology and Venereology (2024)
Open Access | Times Cited: 2

Unraveling Ritlecitinib: an in-depth analysis of JAK3 inhibitor for the treatment of alopecia areata
M. López- Núñez, Supratik Kar, Katherine A. Rodriguez, et al.
Expert Opinion on Drug Metabolism & Toxicology (2024), pp. 1-14
Closed Access | Times Cited: 1

Hair regrowth in alopecia areata and re‐pigmentation in vitiligo in response to treatment: Commonalities and differences
Hiroki L. Yamaguchi, Yuji Yamaguchi, Elena Peeva
Journal of the European Academy of Dermatology and Venereology (2024)
Open Access | Times Cited: 1

Humanized CXCL12 antibody delays onset and modulates immune response in alopecia areata mice: insights from single-cell RNA sequencing
Seungchan An, Mei Zheng, In Guk Park, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1

A review of TEC family kinases and their inhibitors in the treatment of alopecia areata
Yinglin An, Fan Zhang
Archives of Dermatological Research (2024) Vol. 316, Iss. 8
Closed Access

Innovation in Alopecia Areata
Luiza Kalil, Brett King
Dermatologic Clinics (2024) Vol. 43, Iss. 1, pp. 27-33
Closed Access

The Advances in Treatment Options for Conditions Causing Hair Loss
Lily Kaufman, Brittany Dulmage
EMJ Dermatology (2024), pp. 117-121
Open Access

Alopecia areata: Time for position statement to include new systemic therapeutic advances
Julien Séneschal
Journal of the European Academy of Dermatology and Venereology (2024) Vol. 38, Iss. 4, pp. 631-632
Open Access

Advances in the Research of the Immunological Mechanisms of Alopecia Areata
敏 王
Advances in Clinical Medicine (2024) Vol. 14, Iss. 04, pp. 489-496
Closed Access

Non-Scarring Alopecia in Females: A Comprehensive Review
Miguel Aristizabal, Alison J. Bruce, Roy S. Rogers, et al.
EMJ Dermatology (2024)
Open Access

Causal roles of skin and gut microbiota in skin appendage disorders suggested by genetic study
Yuhang Zhu, Wanguo Liu, Mei Wang, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access

Page 1 - Next Page

Scroll to top